Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15196409 | 1.00 | CHRM2 (0.45) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL482322 | 1.00 | CHRM2 (0.45) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL5405253 | 0.97 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL21841417 | 0.97 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL4456368 | 0.97 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL3310461 | 0.94 | — | — | |
| SCHEMBL128736 | 0.94 | — | — | |
| SCHEMBL21903169 | 0.94 | CHRM2 (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17675374 | 0.94 | CHRM2 (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL9093899 | 0.92 | CHRM2 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12264349-B2 | Method for producing monoterpenoid compounds | JOHN INNES CENTRE (GB) | 2025-04-01 | — | — | US | claimed |
| US-20210207183-A1 | METHOD FOR PRODUCING MONOTERPENOID COMPOUNDS | JOHN INNES CENTRE (GB) | 2021-07-08 | — | — | US | claimed |
| EP-3802837-A1 | METHOD FOR PRODUCING MONOTERPENOID COMPOUNDS | JOHN INNES CENTRE (GB) | 2021-04-14 | — | — | EP | claimed |
| JP-54119471-A | — | — | None | — | — | JP | disclosed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121586713-A | Quinoline derivatives and pharmaceutical compositions thereof for the treatment of diseases | 百济神州(苏州)生物科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4658741-A1 | LAUNDRY CARE COMPOSITION | Givaudan SA (CH) | 2025-12-10 | — | — | EP | disclosed |
| US-12492355-B2 | 2,4-diethylocta-2,6-dienal and its use as aroma chemical | BASF SE (DE) | 2025-12-09 | — | — | US | disclosed |
| US-20250368600-A1 | USE OF CYCLOHOMOGERANATE ESTERS AS AROMA CHEMICALS | BASF SE (DE) | 2025-12-04 | — | — | US | disclosed |
| WO-2010138790-A1 | ANTIVIRAL COMPOUNDS COMPOSED OF THREE ALIGNED ARYL MOIETIES TO TREAT DISEASES SUCH AS HEPATITIS C | SCHERING CORPORATION (US) | 2010-12-02 | — | — | WO | disclosed |
| WO-2010133528-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-11-25 | — | — | WO | disclosed |
| EP-2162932-A2 | TETRACARBOXYLIC DIIMIDE SEMICONDUCTOR FOR THIN FILM TRANSISTORS | Eastman Kodak Company (US) | 2010-03-17 | — | — | EP | disclosed |
| WO-2009005669-A2 | TETRACARBOXYLIC DIIMIDE SEMICONDUCTOR FOR THIN FILM TRANSISTORS | EASTMAN KODAK COMPANY (US) | 2009-01-08 | — | — | WO | disclosed |
| US-20090001354-A1 | HETEROCYCLOALKYL-SUBSTITUTED NAPHTHALENE-BASED TETRACARBOXYLIC DIIMIDE COMPOUNDS AS N-TYPE SEMICONDUCTOR MATERIALS FOR THIN FILM TRANSISTORS | BANK OF AMERICA, N.A., AS AGENT | 2009-01-01 | — | — | US | disclosed |
| US-7318843-B2 | Fabric care composition and method for using same | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-15 | — | — | US | disclosed |
| US-7318843-B2 | Fabric care composition and method for using same | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-15 | — | — | US | disclosed |
| JP-S54119471-A | PERFLUORO(2-OXABICYCLO4,4,0DECANE) AND ITS PREPARATION | AGENCY OF IND SCIENCE & TECHNOL | 1979-09-17 | — | — | JP | disclosed |
| EP-0000257-A1 | Benzo(c)pyran derivatives, process for their preparation and their use in perfumery. | BUSH BOAKE ALLEN Limited (GB) | 1979-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368600-A1 | USE OF CYCLOHOMOGERANATE ESTERS AS AROMA CHEMICALS | DECR1, TECR, AKR1C2 | CHRM2 1505/4885CHRM4 1780/4885CHRM5 1043/4885 |
| US-20090001354-A1 | HETEROCYCLOALKYL-SUBSTITUTED NAPHTHALENE-BASED TETRACARBOXYLIC DIIMIDE COMPOUNDS AS N-TYPE SEMICONDUCTOR MATERIALS FOR THIN FILM TRANSISTORS | TEC, NBAS, NMT2 | CHRM2 2650/4885CHRM4 1646/4885CHRM5 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.